What's new in IDIS/Web:

 • New Drugs

 • Drug Name/Code Changes

 • FDA Approval Packages

 • Advisory Committee Meetings

 • Black Box Warnings

 • Priority Clinical Practice Guidelines

 • Continuing Education Articles

 

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

Email: idis@uiowa.edu


Drug Information Resources

IDIS Logo   IDIS Monthly Update Information - February 2012

NEW DRUG TERM
ASK-8007
ASUNAPREVIR
BUDIODARONE
CENERSEN
DACLATASVIR
EUCOMMIA ULMOIDES
FACTOR IX RECOMBINANT FC
SL-65047200
VX-809
XEN-402

CODE
82000560
8180119
24040111
14000722
8180120
92510284
20121624
20400026
92000377
28081271


DRUG NAME/CODE CHANGES

OLD TERM & CODENEW TERM & CODE
OLIGONUCLEOTIDE, IMMUNO STIM 14000714OLIGONUCLEOTIDE, IMMUNO STIM 14000081
SCH-530348 20120674VORAPAXAR 20120674


FDA APPROVAL PACKAGES

Article Numbers 671036-671049: Ruxolitinib, Jakafi Tablets, FDA Approval Package for NDA 202192. FDA Approval Package 2011.

Article Numbers 671021-671035: Aflibercept, Eylea, FDA Approval Package for BLA 125387. FDA Approval Package 2011.


ADVISORY COMMITTEE MEETINGS

Article Numbers 671210-671216: Antiviral Drugs Advisory Committee Meeting, December 14-15, 2011. FDA Advisory Committee 2011,

Article Numbers 671202-671209: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee, December 1, 2011. FDA Advisory Committee 2011.

Article Numbers 671126-671131: Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, December 9, 2011. FDA Advisory Committee 2011.

Article Numbers 671120-671125: Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, December 8, 2011. FDA Advisory Committee 2011.


BLACK BOX WARNINGS

Article Number 671051: Fosphenytoin: FDA Black Box Warning. 2011.

Article Number 671050: Dronedarone: FDA Black Box Warning. 2011.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 669621: Hillis L D, Smith P K, Anderson J L, Bittl J A, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Anesth Analg 2012, 114:11-45.


CONTINUING EDUCATION ARTICLES

Article Number 671196: Anonymous. Intranasal Ketorolac (Sprix) (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 671194-671196]. Med Lett Drugs Ther 2012, 54:7-8.

Article Number 671195: Anonymous. Beta-Adrenergic Blockers and Breast Cancer (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 671194-671196]. Med Lett Drugs Ther 2012, 54:6-7.

Article Number 671194: Anonymous. Epidural Corticosteroid Injections for Lumbar and Cervical Radiculopathy (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 671194-671196]. Med Lett Drugs Ther 2012, 54:5-6.

Article Number 671191: Anonymous. Vandetanib (Caprelsa) for Medullary Thyroid Cancer (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 671190 and 671191]. Med Lett Drugs Ther 2012, 54:3-4.

Article Number 671190: Anonymous. Antiviral Drugs for Influenza (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 671190 and 671191]. Med Lett Drugs Ther 2012, 54:1-3.

Article Number 671188: Anonymous. Safety of Dronedarone (Multaq) (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 671183-671188]. Med Lett Drugs Ther 2011, 53:103-104.

Article Number 671187: Anonymous. Who Should Take Vitamin Supplements? (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 671183-671188]. Med Lett Drugs Ther 2011, 53:101-103.

Article Number 671186: Anonymous. Fentanyl Nasal Spray (Lazanda) for Pain (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 671183-671188]. Med Lett Drugs Ther 2011, 53:99-100.

Article Number 671185: Anonymous. Belatacept (Nulojix) for Prevention of Renal Transplant Rejection (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 671183-671188]. Med Lett Drugs Ther 2011, 53:98-99.

Article Number 671184: Anonymous. Bleeding with Dabigatran (Pradaxa) (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 671183-671188]. Med Lett Drugs Ther 2011, 53:98.

Article Number 671183: Anonymous. Rivaroxaban (Xarelto) for Acute Coronary Syndrome (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 671183-671188]. Med Lett Drugs Ther 2011, 53:97.

Article Number 670891: Cada D J, Levien T L, Baker D E. Ticagrelor (0.15 CEU). Hosp Pharm 2012, 47:47-56.

Article Number 670881: Patterson J H, Adams K F, Human T, Rhoney D H. Case Studies in Hypervolemic Hyponatremia (0.2 CEU) [IDIS Note: The 2.0 Hours of CE Credit is for All Articles in this Issue, Article Numbers 670877-670881]. Hosp Pharm 2011, 46:S39-S44.

Article Number 670880: Rhoney D H. Cost Issues in Hyponatremia (0.2 CEU) [IDIS Note: The 2.0 Hours of CE Credit is for All Articles in this Issue, Article Numbers 670877-670881]. Hosp Pharm 2011, 46:S30-S38.

Article Number 670879: Human T. Therapeutic Options in Managing Hyponatremia: Focus on Arginine Vasopressin Receptor Antagonists (0.2 CEU) [IDIS Note: The 2.0 Hours of CE Credit is for All Articles in this Issue, Article Numbers 670877-670881]. Hosp Pharm 2011, 46:S20-S29.

Article Number 670878: Adams K F . Scientific Basis of Hyponatremia and Its Clinical Presentations (0.2 CEU) [IDIS Note: The 2.0 Hours of CE Credit is for All Articles in this Issue, Article Numbers 670877-670881]. Hosp Pharm 2011, 46:S11-S19.

Article Number 670877: Patterson J H. Hyponatremia's Impact on Patients and Health Systems (0.2 CEU) [IDIS Note: The 2.0 Hours of CE Credit is for All Articles in this Issue, Article Numbers 670877-670881]. Hosp Pharm 2011, 46:S3-S10.

Article Number 670876: Cada D J, Levien T L, Woodruff C R, Baker D E. Rivaroxaban (0.15 CEU). Hosp Pharm 2011, 46:960-970.

Article Number 670107: Anonymous. Drugs for Hypertension (0.2 CEU). Treat Guidel Med Lett 2012, 10:1-10.


College of Pharmacy